 |
|
Early Promise Of New Treatment To Reduce Infection Associated With Chemotherapy (P 275)
January 23, 2003Authors of a fast-track study in this week's issue of THE LANCET propose an alternative to antibiotics to treat infection associated with the use of chemotherapy for patients with blood cancer.
The toxic effects of chemotherapy cause organisms in the gut to migrate to the bloodstream, frequently resulting in bacterial infection. Michael Ellis and colleagues from the United Arab Emirates investigated whether interleukin 11 (IL-11)-an agent involved in the immune response and thought to protect gastrointestinal cells from toxicity associated with chemotherapy-could prevent gut-associated infections.
40 patients with blood cancer received either 50 microgrammes per kg bodyweight of IL-11 or placebo as daily injections. Significantly fewer patients who received IL-11 rather than placebo developed bacterial infection, particularly of gastrointestinal origin. IL-11 slowed the time to first infection compared with placebo
Michael Ellis comments: "The administration of IL-11 reduces bacteraemia, predominantly of gastrointestinal origin, in patients with haemological malignant disease undergoing chemotherapythe number of patients enrolled was small, so larger clinical trials should be done to confirm our findings. If our findings are substantiated, IL-11 could offer a new non-antibiotic approach to the management of sepsis in these patients."
Contact: Dr Michael E Ellis, Department of Medicine, Faculty of Medicine and Health Sciences, PO Box 17666, Al Ain, United Arab Emirates; T) +971 3722 3942; E) michael.ellis@uaeu.ac.ae
Lancet
Chemotherapy Current Events and Chemotherapy News RSSDormant stem cells for emergencies
Many specialized cells, such as in the skin, intestinal mucosa or blood, have a lifespan of only a few days. For these tissues to function, a steady replenishment of specialized cells is indispensable. This is the task of so-called "adult" stem cells also known as tissue stem cells.
Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer
A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to a study posted online ahead of print by Oncogene.
International study supports new standard of treatment for women with advanced ovarian cancer
Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treating advanced ovarian cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course.
Researchers Discover New Enzyme in Cancer Growth
While studying the mechanics of blood clots, researchers at the University of Oklahoma Health Sciences Center discovered a new enzyme that not only affects the blood, but seems to play a primary role in how cancer tumors expand and spread throughout the body.
HER2 levels may aid in treatment selection for metastatic breast cancer
Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit.
Preoperative radiation may improve survival rates in advanced rectal cancer patients
Patients treated with radiation prior to surgery for advanced rectal cancer have fewer instances of cancer recurrence and better overall survival rates, according to a recent Geisinger report.
Studies show novel device may enhance chemotherapy treatment in brain tumors
NovoCure Ltd. presented results yesterday evaluating the Novo-TTF device in vitro and in a pilot clinical trial that showed the device enhanced the efficacy of standard chemotherapy (temozolomide) treatment in newly-diagnosed glioblastoma multiforme (GBM) patients.
Iressa proves just as effective as chemotherapy for lung cancer
Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of non-small cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side effects, according to an international Phase III clinical trial, led by researchers at The University of Texas M. D. Anderson Cancer Center.
Survival of head and neck cancer patients is greatly affected by coexisting ailments
Current estimates for head and neck cancer survival are largely inaccurate because they widely disregard many of the most common diseases such patients have in addition to their primary cancer, says Jay Piccirillo, M.D., a head and neck specialist at Washington University School of Medicine in St. Louis, the Siteman Cancer Center and Barnes-Jewish Hospital.
Study identifies causes of bone loss in breast cancer survivors
Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss.
More Chemotherapy Current Events and Chemotherapy News Articles
 | Questioning Chemotherapy by Ralph W. Moss A revealing critique of chemotherapy, this book looks objectively at chemo's successes and... |
 | The Chemotherapy & Radiation Therapy Survival Guide (Chemotherapy and Radiation Therapy Survivor's Guide) by Judith McKay, Nancee Hirano |
 | Physician's Cancer Chemotherapy Drug Manual 2008 (Jones and Bartlett Series in Oncology) by Edward Chu, Vincent T. DeVita Jr. Completely revised and updated for 2008, this practical handbook is an up-to-date guide to all aspects of cancer chemotherapy. The book provides a comprehensive, easy to use catalogue of over 100 drugs-both on- and off-label-commonly used in cancer treatment. A section on Common Chemotherapy Regimens provides a quick reference to management of specific cancers, arranged... |
 | Health Journeys: A Meditation To Help You With Chemotherapy (Health Journeys) by Belleruth Naparstek Imagery designed to help listeners see their chemotherapy in a positive light; to help reduce aversive side effects, such as fatigue and nausea; to help the body's immune cells fight cancer; to encourage relaxation and a sense of hope, safety, support and peace. With affirmations. (Running time: 41... |
 | Exercises for Chemotherapy Patients by Harry Raftopoulous, Erin O'Driscoll The diagnosis of cancer and the beginning of chemotherapy treatment trigger questions, fears, and feelings of helplessness. But there is one step patients can take immediately to take charge of their health: Exercise.Studies show that, on average, chemotherapy patients who incorporate exercise into their lives have shorter hospital stays, experience a lesser decline in physical functioning,... |
 | The Chemotherapy Source Book The Chemotherapy Source Book, Fourth Edition pulls together all the current information on the chemotherapeutic management of cancer patients, including choice of chemotherapeutic agents, use of combinations, and toxicity of individual drugs. Organized by disease site, the book brings together pharmacologic and patient management information in one source that clinicians can consult for any... |
 | Chemotherapy Heals Cancer and the World is Flat by Lothar Hirneise In the future there will be two groups of cancer patients. Those who have read this book - and those who are uninformed. For many years Lothar Hirneise has been traveling throughout the world looking for the most successful cancer therapies, and he has been explaining to people that there is much more available than just chemotherapy and irradiation. Recognized internationally as Europe's leading... |
 | Pocket Guide to Chemotherapy Protocols, Fourth Edition (Pocket Guide to Chemotherapy Protocols) by Edward Chu An indispensable quick reference for physicians, nurses, and other healthcare providers treating cancer patients! The updated Fourth Edition of the best-selling Pocket Guide to Chemotherapy Protocols is spiral bound and arranged alphabetically by cancer type for easy access, and contains combination as well as selected single-agent regimens for solid tumors and hematologic malignancies. In each... |
 | Chemotherapy and Radiation For Dummies by Alan P. Lyss, Humberto Fagundes, Patricia Corrigan An informative, compassionate guide for cancer patients and their loved ones Each year, more than 1 million people get treated for cancer, and most of these will undergo chemotherapy, radiation therapy, or both. This reassuring, optimistic guide helps people get a handle on treatment options and explains in plain English how chemotherapy and radiation therapy really work. It offers detailed... |
 | Chemotherapy and Biotherapy Guidelines and Recommendations for Practice (second edition) Order your copy of the newly revised and updated second edition of your #1 resource for chemotherapy administration! With more than 46,000 copies sold since 2001, you and thousands of your colleagues in oncology nursing have studied and consulted the information found in the first edition. The new second edition is based on current evidence and has been revised and updated to reflect the... |
| © 2008 BrightSurf.com |